At the news
? BULLISHIMPACT 8/10 PRESS-RELEASE filed Mar 9, 2026 at 16:15 ET
Coherus Oncology reported strong revenue growth for LOQTORZI, with full-year 2025 net revenue reaching $42.2 million, up 60% YoY, driven by increasing patient demand and treatment duration. The company significantly reduced its debt by 90% to $38.8 million and bolstered its cash position to $172.1 million through equity financings, while advancing a promising oncology pipeline with multiple 2026 clinical readouts expected.
- LOQTORZI net revenue grew 60% YoY to $42.2 million in 2025, up from $26.4 million in 2024
- Q4 2025 LOQTORZI revenue was $12.4 million, up 64% YoY and 11% QoQ
- Debt reduced from $480 million peak to $38.8 million by end of 2025
- Cash, cash equivalents, and marketable securities totaled $172.1 million as of December 31, 2025
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access